fibroadenoma

(redirected from fibroadenomas)
Also found in: Thesaurus, Medical, Encyclopedia.

fi•bro•ad•e•no•ma

(ˌfaɪ broʊˌæd nˈoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a benign tumor originating from glandular tissue.
[1890–95]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.fibroadenoma - benign and movable and firm and not tender tumor of the breast; common in young women and caused by high levels of estrogen
adenoma - a benign epithelial tumor of glandular origin
Translations

fi·bro·ad·e·no·ma

n. fibroadenoma, tumor benigno formado por tejido fibroso y glandular.

fibroadenoma

n fibroadenoma m
Mentioned in ?
References in periodicals archive ?
Developed by IceCure Medical (Caesarea, Israel/Memphis, TN), specifically for breast applications, the IceSense3 Cryoablation System(TM), has a long history of successful treatment of benign breast fibroadenomas.
Novilase is FDA 510(k) cleared and can ablate multiple fibroadenomas in a 30-minute outpatient procedure, allowing patients to return to their normal routine immediately.
Frequently discovered in clinical workups for breast cancer diagnosis and during routine breast cancer screening, clinicians often face of challenge of distinguishing fibroadenomas from breast cancer.
Fibroadenomas may increase in size during pregnancy or with estrogen therapy.
Or fibroadenomas, which are lumps of fibrous or glandular tissue in the breast, but this is rare in men.
Fibroadenomas can only grow horizontally along tissue planes.
Long-Term Outcome of Benign Fibroadenomas Treated by Ultrasound-Guided Percutaneous Excision.
They detail the evaluation of fine needle aspirates, core biopsies, wire localization biopsies, and resection specimens, and discuss the normal breast, inflammatory conditions, sclerosing and papillary lesions, fibroadenomas and phyllodes tumors, stromal lesions, diseases of the nipple, fibrocystic changes, ductal and lobular proliferations, and familial breast cancer.
According to the doctor, the two common causes of breast lumps are fibroadenomas and cysts.
Further uses include the evaluation of non-palpable lesions detected on screening mammography, image-guided biopsy of lesions and follow-up of benign lesions such as fibroadenomas.
Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women.